Keyphrases
Heart Failure Clinic
100%
Randomized Clinical Trial
44%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
41%
Tropisetron
33%
Metopimazine
33%
Low-risk Patients
33%
Mortality Prediction
33%
Predictors of Hospitalization
33%
Cisplatin-based Chemotherapy
33%
Placebo
33%
Randomized Double-blind Trial
33%
Antiemetic Effect
33%
Hospitalization
23%
Natriuretic Peptides
22%
Patients with Chronic Heart Failure
22%
Risk Stratification
11%
Discharged Patients
11%
Stable Patients
11%
Symptomatic Patients
11%
Optimal Therapy
11%
Published Data
9%
4-cycle
9%
Outpatient Follow-up
8%
European Countries
8%
Current Guidelines
8%
Clinical High Risk
8%
Optimal Duration
8%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
66%
Metopimazine
33%
Tropisetron
33%
Randomized Clinical Trial
33%
Chemotherapy
33%
Placebo
33%
Cisplatin
33%
Antiemetic Agent
33%
